The Stop TB Program aims to dramatically reduce the global burden of tuberculosis by 2015 in line with WHO and Stop TB partnership goals. One objective is to achieve universal access to high-quality diagnosis and patient-centered treatment for all people with TB, including those co-infected with HIV and drug-resistant cases. Central to the strategy is improving TB case detection and treatment success rates. A long-term goal is to reduce TB prevalence and deaths by 50% from 1990 levels by 2050. The program monitors indicators like new TB cases enrolled in treatment, case detection rates, HIV-TB co-infection, and treatment outcomes.
The Stop TB Program aims to dramatically reduce the global burden of tuberculosis by 2015 in line with WHO and Stop TB partnership goals. One objective is to achieve universal access to high-quality diagnosis and patient-centered treatment for all people with TB, including those co-infected with HIV and drug-resistant cases. Central to the strategy is improving TB case detection and treatment success rates. A long-term goal is to reduce TB prevalence and deaths by 50% from 1990 levels by 2050. The program monitors indicators like new TB cases enrolled in treatment, case detection rates, HIV-TB co-infection, and treatment outcomes.
The Stop TB Program aims to dramatically reduce the global burden of tuberculosis by 2015 in line with WHO and Stop TB partnership goals. One objective is to achieve universal access to high-quality diagnosis and patient-centered treatment for all people with TB, including those co-infected with HIV and drug-resistant cases. Central to the strategy is improving TB case detection and treatment success rates. A long-term goal is to reduce TB prevalence and deaths by 50% from 1990 levels by 2050. The program monitors indicators like new TB cases enrolled in treatment, case detection rates, HIV-TB co-infection, and treatment outcomes.
The Stop TB Program aims to dramatically reduce the global burden of tuberculosis by 2015 in line with WHO and Stop TB partnership goals. One objective is to achieve universal access to high-quality diagnosis and patient-centered treatment for all people with TB, including those co-infected with HIV and drug-resistant cases. Central to the strategy is improving TB case detection and treatment success rates. A long-term goal is to reduce TB prevalence and deaths by 50% from 1990 levels by 2050. The program monitors indicators like new TB cases enrolled in treatment, case detection rates, HIV-TB co-infection, and treatment outcomes.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 4
STOP TB PROGRAM
• Envisioning a tuberculosis free world, the goal of the
Stop TB Program (STP) is to dramatically reduce the global burden of tuberculosis (TB) by 2015. This is in line with the WHO’s millennium development goals and the Stop TB partnership which aims to push the TB up the world political agenda. • One of the objectives of the program is to achieve universal access to high-quality care (i.e.,universal access to high quality diagnosis and patient centered treatment) for all people with TB(including those co- infected with HIV and those with drug-resistant TB). TB CASE DETECTION AND SUCCESSFUL COMPLETION OF THE TREATMENT OR CURE OF TB
• It remains at the core of the Stop TB
Strategy. Thus, by 2050, one of the targets of the strategy is to reduce the prevalence of and death due to TB by 50 percent compared with the 1990 baseline. THE HMIS INDICATORS TO MONITOR STOP TB PROGRAM ARE • TB patients on DOTS (Number of new smear-positive pulmonary TB cases enrolled in the cohort) • TB case detection (Number of new smear –positive pulmonary cases dectected, number of new Smear negative pulmonary TB cases detected, number of new extra-pulmonary TB cases detected). • HIV-TB co-infection(Proportion of newly diagnosed TB cases For HIV). • HIV+ new TB Patient enrolled in DOTS. • TB treatment outcome (Treatment completed PTB+,Cured PTB+,Defaulted PTB+ ,Death PTB+) KEY POINTS TO REMEMBER Monitoring and evaluation(M&E) is a core component of current efforts to scale up for better health. Global partners and countries have developed a general framework for M&E health System strengthening. The primary aim of HMIS is to have a strong M&E and review system in place for the national health strategic plan that comprises all major disease programs and health systems. There are different HMIS indicators which can be used in monitoring the key aspects of health system performance. These are from among the five categories, Namely, reproductive health, immunization, disease prevention and control, resources utilization and data quality. HMIS is a source of routine data that is necessary in monitoring the different aspects of the various health programs implemented in a country. The HMIS indicators should be carefully selected to meet the essential information necessary in monitoring the performance of various health programs and services and to present an overview of the available health resources.
Implementation Status of Household Contact Tuberculosis Screening by Health Extension Workers Assessment Findings From Programme Implementation in Tigray, Region, Northern Ethiopia